FASEB SRC: The Protein Phosphatases Conference
FASEB SRC: The Protein Phosphatases Conference
批准号:
10468584
负责人:
Nunzio Bottini
金额:
$1.45万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-08-01 至 2023-07-31
关键词:
AcademiaAchievementAffectAmericanAreaAttentionAwardBasic ScienceBiochemistryBiologyCOVID-19 pandemicCaliforniaCardiovascular DiseasesCell physiologyCellular biologyChemicalsClinical TrialsCollaborationsCommunitiesComplementDevelopmentDrug TargetingEntrepreneurshipEnvironmentEnzymesEquilibriumEtiologyEventFacultyFamilyFinancial SupportFosteringFundingGoalsGrantHealthHumanHuman PathologyImmune System DiseasesImmune systemIndustrializationIndustryInternationalInvestigationJapaneseJapanese AmericanJointsKnowledgeLifeLinkMalignant NeoplasmsMediatingMetabolic syndromeMinorityMultienzyme ComplexesNervous system structureNobel PrizeNorth AmericaOrganParticipantPathogenesisPathologicPharmaceutical PreparationsPharmacologic SubstancePhosphoric Monoester HydrolasesPhosphorylationPostdoctoral FellowProtein KinaseProtein phosphataseRegulationRequest for ApplicationsResearchResearch PersonnelResortRoleScheduleScientistSeriesSignal TransductionSocietiesStructureSystemSystems BiologyTimeTissuesTransferable SkillsTranslational ResearchValidationWomanWorkcareercareer networkingcohortdesignearly experiencefallsgraduate studenthuman diseaseimprovedinsightinterestlecturesmeetingsminority scientistnervous system disordernew therapeutic targetnovelnovel strategiespostersprotein functionsocial stigmasummer researchsymposiumtherapeutic target
中文摘要
摘要
英文摘要
ABSTRACT
This application requests support for the 2022 edition of the Federation of American Societies for Experimental
Biology (FASEB) Summer Research Conference on Protein Phosphatases. This conference will be the 16th
edition of a recurring series of bi-annual meetings, the sole meeting in North America on this topic held
continuously since 1990. Its 2020 edition had been awarded funding from NCI through R13 CA247237
(scored 26) but unfortunately the conference had to be cancelled because of the COVID-19 pandemic and the
grant was returned to the NCI. We are planning now to re-organize it in 2022 as the first merger between
the two longest-standing world phosphatase conferences: the FASEB protein phosphatase and the
Japanese Association for Protein Phosphatase Research (JAPPR) Conference (at its 15th edition in 2022). The
conference will provide an intense yet collegial environment for researchers to discuss and explore cutting-edge
areas of current research on protein phosphatases and their roles in cellular biology and human pathology. The
2022 conference aims to 1) present the most current work on the structure, regulation and function of the protein
phosphatases with particular attention to their roles in human disease; 2) highlight major achievements and new
approaches, generate conduits to integrate them with other fields of research, and fuel interest in phosphatases
as drug targets; and 3) to renew and refresh the community of phosphatase researchers engaging new and
junior scientists and facilitating ties and collaboration between the FASEB and JAPPR phosphatase research
communities. To achieve this, the 2022 conference is designed to cover the whole range of phosphatase science
from basic to translational. Several scientific sessions are focused on the biochemistry and cell biology of some
of the more than 1000 forms of these complex enzymes. Sessions dedicated to the role of protein phosphatases
in diverse systems and organs—e.g. the nervous and immune systems- provide ideal platforms for cross-
discussion of findings in normal vs pathological tissues and organs. Cancer will be a cross-cutting theme of the
conference and will also be especially featured in two sessions and in the keynote lectures. Recent novel
approaches have been progressively improving druggability of phosphatases, with multiple agents now in
advanced clinical trials. Thus, another cross-cutting theme will be therapeutic targeting of phosphatases.
Speakers will include experts from academia and industry, and talks on late-breaking advances and short talks
selected from submitted abstracts will be given by new investigators, graduate students, post-doctoral fellows,
and those from outside the field with a goal of increasing representation by women and minority scientists. The
Omni Resort in Palm Springs provides a secluded venue that fosters informal interaction, discussion, and
collaboration between the expected 150 participants. Altogether, the impact of the 2022 FASEB Conference on
Protein Phosphatases will be to augment our understanding of fundamental protein phosphatase biology and
pave the way for development of new therapies targeting phosphatases to improve human health.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cadherin-11-cre deleter mouse
-
批准号:10784524
-
项目类别:
-
资助金额:$28.69万
-
财政年份:2023
-
负责人:Nunzio Bottini
-
依托单位:
Role of PTP4A1 in systemic sclerosis
-
批准号:10668208
-
项目类别:
-
资助金额:$64.76万
-
财政年份:2022
-
负责人:Nunzio Bottini
-
依托单位:
Small molecule inhibitors of LMPTP: an obesity drug target
-
批准号:10669954
-
项目类别:
-
资助金额:$52.66万
-
财政年份:2022
-
负责人:Nunzio Bottini
-
依托单位:
Functional plasticity of Th17 in arthritis
-
批准号:10201506
-
项目类别:
-
资助金额:$19.74万
-
财政年份:2020
-
负责人:Nunzio Bottini
-
依托单位:
Role of LMPTP in cardiac fibrosis
-
批准号:10705848
-
项目类别:
-
资助金额:$56.31万
-
财政年份:2020
-
负责人:Nunzio Bottini
-
依托单位:
Role of LMPTP in cardiac fibrosis
-
批准号:10668888
-
项目类别:
-
资助金额:$64.09万
-
财政年份:2020
-
负责人:Nunzio Bottini
-
依托单位:
Role of PTPN2 in rheumatoid arthritis
-
批准号:10404920
-
项目类别:
-
资助金额:$52.64万
-
财政年份:2019
-
负责人:Nunzio Bottini
-
依托单位:
Role of PTPN2 in rheumatoid arthritis
-
批准号:10852548
-
项目类别:
-
资助金额:$55.64万
-
财政年份:2019
-
负责人:Nunzio Bottini
-
依托单位:
Role of PTP4A1 in systemic sclerosis
-
批准号:10021705
-
项目类别:
-
资助金额:$58.26万
-
财政年份:2019
-
负责人:Nunzio Bottini
-
依托单位:
Role of PTPN2 in rheumatoid arthritis
-
批准号:10155408
-
项目类别:
-
资助金额:$52.63万
-
财政年份:2019
-
负责人:Nunzio Bottini
-
依托单位:
Role of PTP4A1 in systemic sclerosis
-
批准号:10199030
-
项目类别:
-
资助金额:$58.24万
-
财政年份:2019
-
负责人:Nunzio Bottini
-
依托单位:
Resource-based Center for the study of the joint microenvironment in rheumatology (Overall Application)
-
批准号:9767026
-
项目类别:
-
资助金额:$78.28万
-
财政年份:2018
-
负责人:Nunzio Bottini
-
依托单位:
Administrative Core of the MARC
-
批准号:10254250
-
项目类别:
-
资助金额:$28.18万
-
财政年份:2018
-
负责人:Nunzio Bottini
-
依托单位:
Resource-based Center for the study of the joint microenvironment in rheumatology (Overall Application)
-
批准号:10254249
-
项目类别:
-
资助金额:$77.54万
-
财政年份:2018
-
负责人:Nunzio Bottini
-
依托单位:
Joint Cell Isolation Core of the MARC
-
批准号:10007638
-
项目类别:
-
资助金额:$16.51万
-
财政年份:2018
-
负责人:Nunzio Bottini
-
依托单位:
Administrative Core of the MARC
-
批准号:10007635
-
项目类别:
-
资助金额:$28.23万
-
财政年份:2018
-
负责人:Nunzio Bottini
-
依托单位:
Resource-based Center for the study of the joint microenvironment in rheumatology (Overall Application)
-
批准号:10007597
-
项目类别:
-
资助金额:$77.83万
-
财政年份:2018
-
负责人:Nunzio Bottini
-
依托单位:
Joint Cell Isolation Core of the MARC
-
批准号:10254252
-
项目类别:
-
资助金额:$16.46万
-
财政年份:2018
-
负责人:Nunzio Bottini
-
依托单位:
Role of PTP4A1 in systemic sclerosis
-
批准号:9182480
-
项目类别:
-
资助金额:$17.05万
-
财政年份:2016
-
负责人:Nunzio Bottini
-
依托单位:
Role of PTP4A1 in systemic sclerosis
-
批准号:9316511
-
项目类别:
-
资助金额:$20.46万
-
财政年份:2016
-
负责人:Nunzio Bottini
-
依托单位:
海外基金